This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of other and unspecified parts of face
CD2_BENIGN_MELANOCYTIC_FACE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) faciei
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of other and unspecified parts of face
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of other and unspecified parts of face
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2330 | 1635 | 695 |
| Unadjusted period prevalence (%) | 0.48 | 0.56 | 0.31 |
| Median age at first event (years) | 48.85 | 45.85 | 55.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2068
- Matched controls
- 20678
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
46.8
323.0
867
314
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
10076.7
323.0
1998
81
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
366.5
198.2
197
6
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.3
181.1
439
652
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
137.0
130
*
PJA12
NOMESCO Finland
Sentinel node biopsy
387.6
111.5
111
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
106.2
101
*
115
Kela drug reimbursment
Breast cancer
+∞
99.8
95
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
18.3
91.3
144
84
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
12.4
88.9
165
143
L57.0
ICD-10 Finland
Actinic keratosis
5.6
82.7
260
518
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.0
79.7
234
428
C61
ICD-10 Finland
Malignant neoplasm of prostate
407.7
79.4
79
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
78.6
75
*
H02AB02
ATC
dexamethasone; systemic
16.9
77.7
126
79
2163A
ICD-9 Finland
Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]
+∞
77.6
74
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
202.5
75.7
78
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
17.1
74.4
120
74
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.8
73.9
197
316
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
5.2
71.2
236
497
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.3
71.1
406
1409
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
68.1
65
*
130
Kela drug reimbursment
Malignant tumour
+∞
68.1
65
*
TQW99
NOMESCO Finland
Other minor procedure on skin
7.9
67.2
160
217
L82
ICD-10 Finland
Seborrhoeic keratosis
3.1
63.6
403
1495
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
56.5
54
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
91.3
56.2
62
7
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
55.5
53
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
49.1
47
*
ZZR00
NOMESCO Finland
Flap of skin
25.4
49.1
69
28
HAC20
NOMESCO Finland
Total mastectomy
245.5
47.2
48
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
47.0
45
*
L02BA01
ATC
tamoxifen; oral
167.2
47.0
49
*
116
Kela drug reimbursment
Prostate cancer
+∞
46.0
44
*
A04AA02
ATC
granisetron; systemic, transdermal
46.1
44.3
54
12
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.6
43.0
158
367
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
41.8
40
*
S82
ICPC
Naevus/mole
2.6
37.6
306
1293
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
36.6
35
*
S18
ICPC
Laceration/cut
1.9
36.3
804
5261
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
35.6
329
1489
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
35.5
34
*
L03AA13
ATC
pegfilgrastim; parenteral
353.0
35.0
35
*
Z2221
NOMESCO Finland
Medical doctor
1.9
33.7
590
3525
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
33.4
32
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
33.4
32
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
7.8
33.2
78
104
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.9
31.9
92
163
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
167.6
31.8
33
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.5
31.6
96
181
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.3
30
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
39.7
31.2
39
10
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
26.8
30.6
42
16
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
30.3
29
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
306.7
29.9
30
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
29.2
28
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
28.3
737
4978
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.3
28.0
44
26
ZXC50
NOMESCO Finland
Cryotherapy
6.5
27.9
74
118
JN4BD
NOMESCO Finland
Extensive body CT
3.7
27.7
126
356
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
6.9
27.3
69
103
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
98.0
26.7
29
*
9733
FHL
Excision of skin change in operating room or anesthesia
7.4
26.6
64
89
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
6.4
26.3
70
112
SPAT1153
SPAT
Removal of sutures
1.8
26.1
586
3753
WF002
NOMESCO Finland
Radical radiotherapy
21.5
26.1
38
18
C50.99
ICD-10 Finland
Breast, unspecified
+∞
26.1
25
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.9
26.1
50
47
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
73.6
25.8
29
*
XQ845
NOMESCO Finland
Dermatoscopy
11.2
24.9
47
43
XQ848
NOMESCO Finland
Dermatological photography
5.2
24.7
78
155
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
131.6
24.6
26
*
L02BG04
ATC
letrozole; oral
5.1
24.4
78
157
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
24.0
561
3620
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
24.0
23
*
L01BC06
ATC
capecitabine; oral
+∞
24.0
23
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
23.8
662
4500
WF049
NOMESCO Finland
Radiotherapy of metastasis
126.5
23.6
25
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
23.0
22
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
84.4
22.7
25
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
84.4
22.7
25
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
232.4
22.7
23
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
21.9
21
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
21.9
21
*
HA1AA
NOMESCO Finland
X-ray mammography
3.8
21.7
94
256
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.9
21.1
59
102
S77
ICPC
Malignant neoplasm of skin
60.6
20.9
24
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
20.9
20
*
L02BB03
ATC
bicalutamide; oral
+∞
20.9
20
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
37.6
20.8
26
7
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
10.2
19.9
39
39
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
19.8
19
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
19.8
19
*
X76
ICPC
Malignant neoplasm breast female
+∞
19.8
19
*
I78.1
ICD-10 Finland
Naevus, non-neoplastic
4.9
19.7
65
136
ZXA00
NOMESCO Finland
Right side
1.7
19.7
475
3067
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
5.2
19.7
61
119
L03AA02
ATC
filgrastim; parenteral
46.5
19.2
23
5
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.4
19.1
37
36
ZXE00
NOMESCO Finland
One hour or less
1.6
18.9
738
5408
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
18.8
18
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
18.8
18
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
18.8
18
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
18.8
18
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
70.5
18.7
21
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.7
18.6
47
71
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
191.6
18.6
19
*
D22
ICD-10 Finland
Melanocytic naevi
2.9
18.3
115
412
ZXA05
NOMESCO Finland
Left side
1.7
18.1
433
2783
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
18.0
446
2892
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.4
18.0
87
260
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.2
18.0
69
169
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
23.0
17.7
25
11
Y77
ICPC
Malignant neoplasm prostate
+∞
17.7
17
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
17.7
17
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
17.7
17
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
17.7
17
*
A04AA01
ATC
ondansetron; systemic, rectal
3.7
17.5
77
213
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
181.5
17.5
18
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
18.8
17.3
26
14
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
16.7
16
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
16.7
16
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
16.7
16
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
16.7
16
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.6
15.7
20
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
15.7
217
1156
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
15.6
15
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
15.6
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.6
15
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
15.6
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
15.6
102
377
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
15.2
343
2154
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
28.8
15.2
20
7
A02BC02
ATC
pantoprazole; systemic
1.5
15.2
1155
9619
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
5.3
15.2
46
89
R4110
NOMESCO Finland
Physiotherapy
1.6
15.1
430
2882
J01DB01
ATC
cefalexin; oral
1.5
15.0
1584
14104
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.9
14.9
48
99
WX110
NOMESCO Finland
Local anesthesy
1.5
14.8
1308
11197
WX402
NOMESCO Finland
General anaesthesia
1.8
14.8
259
1501
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
14.6
14
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
14.6
14
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.6
14
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
14.6
14
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.6
14
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
14.6
14
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
14.6
14
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
14.6
14
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
151.0
14.5
15
*
A79
ICPC
Malignancy NOS
151.0
14.5
15
*
WF004
NOMESCO Finland
Palliative radiotherapy
151.0
14.5
15
*
Z3231
NOMESCO Finland
Registered nurse
1.6
13.9
461
3204
S29
ICPC
Skin symptom/complaint other
1.7
13.8
294
1810
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
13.6
13
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
13.6
13
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
13.6
13
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
13.6
13
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
13.6
13
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
13.6
13
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
13.6
13
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
140.9
13.5
14
*
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
7.5
13.4
31
42
DAB00
NOMESCO Finland
Excision of lesion of auricle
10.5
13.2
25
24
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
9.7
13.2
26
27
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
13.1
491
3503
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
12.2
13.1
23
19
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.8
13.0
32
48
A04AD12
ATC
aprepitant; systemic
50.3
12.8
15
*
L02BG03
ATC
anastrozole; oral
50.3
12.8
15
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
12.7
426
2958
B01AB05
ATC
enoxaparin; parenteral
1.5
12.6
444
3120
ZXC20
NOMESCO Finland
Use of chemical agents
5.2
12.6
38
74
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
12.5
12
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
12.5
12
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
12.5
12
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
12.5
12
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
12.5
12
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
130.8
12.4
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
12.3
661
5076
ZX120
NOMESCO Finland
Intravenous
2.2
12.3
128
607
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.8
12.1
51
138
S21
ICPC
Skin texture symptom/complaint
1.8
12.1
218
1274
Z51.5
ICD-10 Finland
Palliative care
4.7
12.0
40
87
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.8
11.9
39
83
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
16.5
11.7
18
11
F16
ICPC
Eyelid symptom/complaint
2.4
11.7
97
412
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
11.5
11
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
11.5
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
N02BE01
ATC
paracetamol; systemic, rectal
1.5
11.4
1623
14769
L02AE02
ATC
leuprorelin; implant, parenteral
4.2
11.4
42
101
JN4AD
NOMESCO Finland
Body CT examination
3.1
11.4
61
200
TQW20
NOMESCO Finland
Tatoe
35.2
11.3
14
*
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
10.1
11.0
21
21
Z31.5
ICD-10 Finland
Genetic counselling
2.4
10.9
88
370
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
10.9
80
320
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.3
10.8
23
28
E0000UV
ATC
NA
1.4
10.8
715
5676
ZQZ00
NOMESCO Finland
Treatment of several skin areas
17.9
10.7
16
9
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
10.6
373
2609
D22.0
ICD-10 Finland
Melanocytic naevi of lip
11.3
10.5
19
17
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
8.5
10.5
22
26
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
110.6
10.4
11
*
L02BG06
ATC
exemestane; oral
110.6
10.4
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.4
10
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
10.4
10
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
10.4
10
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.4
10
*
L72.1
ICD-10 Finland
Trichilemmal cyst
2.1
10.4
112
540
ZZA50
NOMESCO Finland
Full thickness skin graft
18.9
10.3
15
8
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.2
10.0
36
86
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
40.3
10.0
12
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
40.3
10.0
12
*
UJF32
NOMESCO Finland
Coloscopy
1.5
10.0
392
2807
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
10.0
304
2057
ZXD20
NOMESCO Finland
Day surgery
1.6
9.7
238
1521
QAA10
NOMESCO Finland
Incision of skin of head or neck
55.2
9.6
11
*
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
3.9
9.5
37
95
ZXA10
NOMESCO Finland
Bilateral
1.5
9.5
309
2121
ZXC96
NOMESCO Finland
Robot assisted procedure
7.2
9.5
22
31
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
9.4
256
1682
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
100.5
9.4
10
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.2
9.4
47
148
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
30.2
9.4
12
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
9.4
9
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
N63
ICD-10 Finland
Unspecified lump in breast
2.1
9.2
104
512
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
5.7
9.2
25
44
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.1
621
4922
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.9
9.1
53
186
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
36.8
9.0
11
*
JN4CD
NOMESCO Finland
Very extensive body CT
4.1
9.0
33
81
A02BC05
ATC
esomeprazole; systemic
1.4
8.9
686
5540
XKD00
NOMESCO Finland
Uroflowmetry
1.7
8.8
173
1037
J05AB11
ATC
valaciclovir; oral
1.6
8.8
221
1420
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
8.8
120
637
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
8.8
449
3378
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
8.7
520
4021
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.6
8.7
61
240
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
50.2
8.7
10
*
Z01.7
ICD-10 Finland
Laboratory examination
1.7
8.6
195
1219
B01AB10
ATC
tinzaparin; parenteral
2.3
8.6
77
342
127
Kela drug reimbursment
Transplant complication
4.0
8.5
32
80
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
16.3
8.5
13
8
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
16.3
8.5
13
8
J01FA10
ATC
azithromycin; systemic
1.3
8.5
1116
9739
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.7
8.5
183
1127
Z3226
NOMESCO Finland
Physiotherapist
1.5
8.5
289
2001
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
8.3
8
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
8.3
8
*
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
8.3
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.3
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.3
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
8.3
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.3
8.2
674
5482
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.2
310
2197
Z94.0
ICD-10 Finland
Kidney transplant status
4.5
8.2
27
60
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
5.2
8.2
24
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.0
8.1
43
143
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
33.5
8.1
10
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
33.5
8.1
10
*
L04AA01
ATC
[U] ciclosporin; systemic
3.8
8.0
32
85
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
22.1
8.0
11
5
D03.5
ICD-10 Finland
Melanoma in situ of trunk
22.1
8.0
11
5
WZC30
NOMESCO Finland
Teaching
1.8
8.0
145
852
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
5.9
8.0
21
36
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
8.0
209
1360
L91.0
ICD-10 Finland
Hypertrophic scar
3.8
7.9
32
86
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
7.9
146
861
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.9
679
5557
EMB10
NOMESCO Finland
Tonsillectomy
1.9
7.9
115
629
S04
ICPC
Lump/swelling localized
1.7
7.9
156
941
BAA60
NOMESCO Finland
Total thyroidectomy
3.2
7.8
39
125
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
45.1
7.7
9
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
45.1
7.7
9
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
2.9
7.7
44
152
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
7.7
152
915
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
7.7
625
5069
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
18.4
7.6
11
6
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
4.5
7.6
25
56
G04CA02
ATC
tamsulosin; oral
1.5
7.6
233
1578
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
7.5
144
859
ZZA00
NOMESCO Finland
Split skin graft
3.0
7.4
40
135
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
7.4
34
102
C90.0
ICD-10 Finland
Multiple myeloma
80.4
7.4
8
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.4
7.4
8
*
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
80.4
7.4
8
*
N02AA05
ATC
oxycodone; systemic
1.7
7.4
148
894
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
7.4
120
679
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.4
409
3112
CBA10
NOMESCO Finland
Biopsy of eyelid
6.5
7.4
18
28
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.4
928
7989
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
7.3
7
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
7.3
7
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
7.3
7
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
7.3
7
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
180
Kela drug reimbursment
Interferon alfa
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
7.3
7
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
7.3
7
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
10.9
7.3
13
12
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
15.8
7.2
11
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
7.2
295
2121
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
7.2
504
3987
S26
ICPC
Fear of cancer of skin
5.3
7.1
20
38
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
5.3
7.1
20
38
J35.0
ICD-10 Finland
Chronic tonsillitis
1.9
7.1
104
571
J01DA01
ATC
[U] cefalexin; systemic
1.3
7.0
1140
10126
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
3.7
6.9
28
77
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.4
6.8
23
53
D03.30
ICD-10 Finland
Melanoma in situ on the lip
40.2
6.8
8
*
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
40.2
6.8
8
*
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
16.7
6.7
10
6
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
16.7
6.7
10
6
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.7
261
1858
J01EA01
ATC
trimethoprim; systemic
1.4
6.7
439
3431
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
4.1
6.7
24
59
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
6.7
146
906
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
22.6
6.7
9
*
HA1HA
NOMESCO Finland
Tomosynthesis mammography
22.6
6.7
9
*
D18.0
ICD-10 Finland
Haemangioma, any site
2.6
6.7
44
169
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
6.6
1339
12181
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
6.6
115
669
Z71.8
ICD-10 Finland
Other specified counselling
1.4
6.5
404
3127
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
6.5
185
1227
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.5
390
3005
-59
ICPC
Other therap proced/minor surg NEC
2.5
6.4
47
192
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
70.1
6.4
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
70.1
6.4
7
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
70.1
6.4
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.1
6.4
7
*
D06BB10
ATC
imiquimod; topical
2.1
6.4
72
357
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
6.4
34
115
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
14.3
6.4
10
7
WW500
NOMESCO Finland
Blood transfusion
2.7
6.4
39
144
S08
ICPC
Skin colour change
2.0
6.4
74
372
S59
ICPC
Skin, Other therap proced/minor surg NEC
3.8
6.4
25
67
ZX112
NOMESCO Finland
Subcutaneous
4.6
6.3
20
44
A98
ICPC
Health maint/preventive medicine
1.6
6.3
1947
18821
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
6.3
6
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
6.3
6
*
L01CA04
ATC
vinorelbine; systemic
+∞
6.3
6
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
6.3
6
*
189
Kela drug reimbursment
Imatinib
+∞
6.3
6
*
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
+∞
6.3
6
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
6.3
6
*
R74
ICPC
Upper respiratory infection acute
1.3
6.2
537
4371
-
ICD-10 Finland
NA
2.5
6.2
45
184
J02AC01
ATC
fluconazole; systemic
1.3
6.2
757
6456
B03XA01
ATC
erythropoietin; parenteral
5.7
6.1
16
28
Z01.2
ICD-10 Finland
Dental examination
1.3
6.1
732
6220
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
6.1
422
3326
J01FA09
ATC
clarithromycin; systemic
1.3
6.0
561
4608
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.0
1208
10912
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
1246
6568
2.93
140.03
2.7
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
444
1580
3.24
96.33
1.4
1.1
—
—
—
0
0
(4035726)
183
560
3.46
49.40
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
207
794
2.76
37.65
3.3
1.5
ug/l
28.9
3.3
0.57
156
580
(3013650) Neutrophils [#/volume] in Blood by Automated count
1285
9994
1.64
29.09
9.0
6.6
e9/l
3.8
4.1
5.49
1111
8672
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1093
8239
1.62
27.53
6.2
3.8
umol/l
10.9
11.1
0.15
1029
7687
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
26
20
13.14
27.15
6.4
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
614
4097
1.68
24.56
4.2
3.4
%
92.1
92.5
0.15
600
3974
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1603
13469
1.61
23.95
7.9
5.3
u/l
76.7
74.3
1.25
1504
12519
(3024561) Albumin [Mass/volume] in Serum or Plasma
919
6871
1.56
22.53
4.7
3.7
g/l
36.3
36.3
0.01
856
6339
(40758558) Short blood count panel - Blood
613
4188
1.63
21.96
6.7
4.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1138
9043
1.51
20.31
6.0
5.5
e9/l
0.6
0.6
0.99
988
7863
(3006315) Basophils [#/volume] in Blood
1142
9083
1.50
20.28
6.0
5.5
e9/l
0.0
0.0
1.17
991
7890
(42870588) Differential panel, method unspecified - Blood
787
5801
1.54
19.96
6.0
5.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1174
9417
1.50
19.84
6.3
5.7
e9/l
0.2
0.2
0.27
1031
8320
(3002582) Erythrocytes [#/volume] in Urine
689
4950
1.56
19.54
3.2
2.9
e6/l
29.4
82.2
2.29
524
3725
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1037
8128
1.50
19.52
6.7
5.2
mmol/l
1.2
1.2
0.46
905
6865
(3015377) Calcium [Moles/volume] in Serum or Plasma
734
5401
1.52
18.45
3.3
2.0
mmol/l
2.4
2.4
0.13
633
4629
(3019198) Lymphocytes [#/volume] in Blood
1158
9366
1.47
18.13
6.0
5.5
e9/l
2.0
1.9
0.67
1027
8311
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
933
7266
1.47
17.55
6.0
4.8
mmol/l
1.2
1.2
0.43
858
6464
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1011
8009
1.46
17.35
4.2
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
804
6099
1.49
17.17
3.8
3.3
e6/l
49.0
91.9
2.54
560
4071
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
301
1814
1.76
16.90
2.9
2.2
umol/l
7.9
6.6
0.49
258
1540
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
411
2705
1.63
16.57
2.7
2.4
e6/l
0.9
1.3
1.14
224
1485
(3006504) Eosinophils/100 leukocytes in Blood
1051
8437
1.45
16.56
6.1
5.6
%
2.8
2.9
0.44
982
7818
(3030467) Casts [#/volume] in Urine by Automated count
622
4507
1.52
16.46
3.1
2.8
e6/l
0.4
0.4
0.28
448
3327
(3018418) pH of Serum or Plasma
643
4703
1.51
16.24
4.6
3.1
ph
7.4
7.4
0.52
78
802
(3022096) Basophils/100 leukocytes in Blood
1020
8166
1.44
16.19
6.2
5.7
%
0.7
0.7
0.32
955
7567
(3019069) Monocytes/100 leukocytes in Blood
1053
8488
1.44
16.06
6.3
5.9
%
8.4
8.3
0.19
992
7916
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
381
2493
1.63
15.66
2.7
2.5
e6/l
3.9
3.5
0.21
197
1279
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
19
21
9.11
15.55
6.9
1.0
u/ml
39.9
17.4
0.84
19
21
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2064
19122
1.70
14.52
13.9
11.0
mg/l
21.6
20.8
0.50
1627
14666
(3002030) Lymphocytes/100 leukocytes in Blood
1072
8775
1.41
14.47
6.2
5.6
%
29.3
29.0
0.30
1007
8160
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
161
839
1.99
14.24
2.4
1.5
u/ml
85.0
25.8
1.01
155
801
(3007853) Bacteria identified in Skin by Aerobe culture
314
2008
1.65
14.04
1.5
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
670
5062
1.45
14.00
2.4
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
5909
1.43
13.64
3.4
2.6
u/l
30.6
33.6
0.50
722
5614
(3019550) Sodium [Moles/volume] in Serum or Plasma
2078
19345
1.69
13.61
15.6
12.4
mmol/l
139.7
139.7
0.18
2036
18793
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
78
307
2.59
13.50
3.0
2.1
u/ml
321.8
54.2
0.52
63
237
(3018010) Neutrophils/100 leukocytes in Blood
1057
8700
1.39
13.48
6.0
5.5
%
56.1
56.7
0.87
994
8111
(3003338) MCHC [Mass/volume]
1857
16865
1.50
13.41
18.8
14.1
g/l
332.1
332.5
1.20
1840
16744
(36304419) Bacteria [Presence] in Urine
597
4449
1.46
13.29
3.1
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1408
12178
1.39
13.21
4.9
4.2
e6/l
376.4
2158.5
2.15
16
152
(3023103) Potassium [Moles/volume] in Serum or Plasma
2081
19412
1.67
13.12
15.8
12.4
mmol/l
3.9
3.9
4.01
2036
18820
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
417
2913
1.53
12.71
2.9
2.1
mmol/l
2.4
2.4
0.14
347
2517
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
236
1442
1.71
12.50
4.5
3.3
u/l
230.0
231.3
0.06
220
1349
(3012095) Magnesium [Moles/volume] in Serum or Plasma
343
2303
1.57
12.48
3.2
2.6
mmol/l
0.8
0.8
0.75
321
2125
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
458
3287
1.49
12.22
3.1
3.5
ng/l
247.0
484.0
0.90
313
2318
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
249
1555
1.67
12.15
2.4
2.2
u/l
33.6
68.0
0.57
207
1309
(3013707) Erythrocyte sedimentation rate by Westergren method
1581
14042
1.39
12.02
4.2
3.9
mm/h
10.6
10.8
0.36
1476
13050
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2147
20279
1.75
11.84
16.0
12.1
umol/l
73.7
73.3
0.28
2147
20270
(3037467) Urinalysis macro (dipstick) panel - Urine
1471
12940
1.37
11.67
4.8
4.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
63
4.49
11.67
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1447
12702
1.37
11.59
3.8
3.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
101
3.60
11.18
5.3
1.1
u/ml
273.1
148.4
0.22
11
30
(3026008) Bacteria identified in Urine by Culture
679
5324
1.39
11.02
3.1
2.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2251
21638
2.19
10.99
21.3
16.3
e9/l
6.6
6.7
0.16
2200
20998
(3035941) MCH [Entitic mass]
2250
21631
2.17
10.87
21.2
16.1
pg
30.1
30.2
1.05
2228
21317
(3026361) Erythrocytes [#/volume] in Blood
2250
21633
2.17
10.84
21.3
16.2
e12/l
4.5
4.5
0.34
2199
20995
(3024731) MCV [Entitic volume]
2249
21629
2.15
10.67
21.3
16.2
fl
90.5
90.6
0.86
2227
21317
(3000963) Hemoglobin [Mass/volume] in Blood
2250
21643
2.15
10.66
21.4
16.3
g/l
135.0
135.8
2.28
2226
21329
(3013826) Glucose [Moles/volume] in Serum or Plasma
1189
10211
1.34
10.54
4.3
4.0
mmol/l
6.5
6.6
1.09
1098
9384
(3002385) Erythrocyte distribution width [Ratio]
1766
16137
1.39
10.19
17.7
13.1
%
13.5
13.5
0.01
1736
15757
(3000850) Epithelial cells [#/volume] in Urine
465
3459
1.43
10.10
2.7
2.3
e6/l
4.4
7.0
4.05
401
2991
(3049717) Cytology report of Urine Cyto stain
88
418
2.15
10.04
2.3
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2244
21615
2.03
9.76
21.4
16.2
e9/l
256.7
257.3
0.17
2199
21035
(3000494) Fungus identified in Specimen by Culture
299
2056
1.52
9.66
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2126
20175
1.61
9.65
12.7
10.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1938
18049
1.44
9.58
5.6
4.7
mu/l
1.8
2.0
0.79
1825
16728
(40768793) Breast Pathology biopsy report
46
168
2.77
9.30
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
1966
1.52
9.25
5.4
5.0
mmol/l
1.1
1.0
0.83
268
1817
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
503
3855
1.39
9.11
2.5
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1976
18508
1.45
9.10
4.5
4.2
mmol/l
5.8
5.8
0.87
1847
17039
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2141
20393
1.61
9.06
10.9
8.4
u/l
26.1
25.4
0.76
2083
19633
(3022145) Colonoscopy Study observation
272
1860
1.52
9.01
1.3
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
205
1315
1.61
8.98
6.0
7.8
g/l
124.2
123.2
0.31
195
1262
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
195
1240
1.62
8.85
3.7
3.0
pmol/l
4.5
4.5
0.19
172
1093
(3023368) Bacteria identified in Blood by Culture
497
3826
1.38
8.72
4.2
3.7
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
25
65
3.88
8.69
34.0
24.0
ug/l
83.3
123.5
4.33
25
54
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
22
6.40
8.53
1.1
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1682
15409
1.33
8.41
4.8
4.0
pmol/l
14.6
14.6
0.40
1558
14182
(3032080) INR in Blood by Coagulation assay
759
6258
1.32
8.38
7.2
8.4
inr
1.2
1.2
2.14
193
1913
(3003396) Base excess in Arterial blood by calculation
239
1615
1.53
8.35
5.5
7.1
mmol/l
0.8
1.2
0.78
177
1227
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
923
7839
1.29
8.10
2.4
2.3
nmol/l
76.7
76.9
0.05
851
7069
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
125
723
1.77
8.07
7.1
10.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1855
17286
1.36
7.96
5.6
5.3
mmol/mol
38.6
39.2
2.37
1761
16143
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
195
1275
1.58
7.89
4.5
3.6
ng/l
82.8
85.2
0.17
181
1106
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
864
7304
1.29
7.77
2.0
1.9
pmol/l
100.8
96.7
1.59
433
3724
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1494
13532
1.29
7.73
3.6
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
60
273
2.23
7.69
1.5
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
44
4.35
7.68
2.0
3.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
119
691
1.76
7.60
1.2
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
236
1631
1.50
7.42
5.6
7.0
kpa
5.1
5.1
0.26
224
1553
(3009542) Hematocrit [Volume Fraction] of Blood
1916
17996
1.36
7.41
16.2
12.0
%
40.1
40.0
0.27
1480
13530
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
185
1213
1.57
7.40
2.1
2.2
g/l
0.2
0.2
0.67
171
1108
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
337
2498
1.41
7.31
1.7
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
235
1631
1.49
7.24
5.6
7.0
kpa
12.7
12.0
1.10
223
1553
(3009261) Glucose [Presence] in Urine by Test strip
1074
9393
1.27
7.15
3.9
3.4
estimate
0.0
0.0
1.32
166
1641
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
514
4106
1.32
6.90
1.7
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
208
1430
1.50
6.71
5.9
7.6
%
95.9
95.3
0.78
196
1379
(3026493) Urate [Moles/volume] in Serum or Plasma
561
4556
1.30
6.66
2.6
2.2
umol/l
2548.4
5139.5
1.32
494
3977
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2030
19318
1.39
6.63
5.0
4.6
mmol/l
2.8
2.8
0.36
1912
17986
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
388
2992
1.36
6.59
4.6
3.5
%
22.4
23.7
0.75
177
1327
(3018677) aPTT in Platelet poor plasma by Coagulation assay
319
2385
1.39
6.56
2.6
2.0
s
30.1
29.6
0.60
308
2298
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
286
2104
1.41
6.46
3.0
2.6
ug/l
0.7
0.7
0.10
183
1312
(3011397) Hemoglobin [Presence] in Urine by Test strip
539
4371
1.30
6.44
4.1
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1887
17786
1.32
6.34
13.1
9.6
ml/min/173m2
84.6
84.4
0.13
1533
14203
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1990
18906
1.36
6.31
4.3
4.1
mmol/l
1.5
1.5
0.18
1863
17627
(3000991) Gas panel - Venous blood
173
1163
1.53
6.22
7.9
7.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
465
3713
1.32
6.20
5.4
3.6
ug/l
2.3
1.9
0.99
412
3340
(3021601) Nitrite [Presence] in Urine by Test strip
1054
9302
1.24
6.15
5.1
4.6
estimate
0.0
0.0
0.50
169
1681
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1998
19020
1.35
6.04
4.4
4.2
mmol/l
4.7
4.7
0.49
1888
17824
(3017446) Testosterone [Moles/volume] in Serum or Plasma
143
931
1.57
5.94
2.5
2.1
nmol/l
11.6
13.1
1.14
135
826
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
196
1368
1.47
5.89
2.5
2.2
ml/min/173m2
66.0
70.5
0.73
77
526
(40768797) Stomach Pathology biopsy report
324
2473
1.36
5.85
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
126
799
1.61
5.85
2.8
2.4
e6/l
0.1
0.2
3.52
120
769
(3020779) Urea [Moles/volume] in Serum or Plasma
175
1196
1.50
5.83
6.9
7.3
mmol/l
10.1
9.3
0.59
161
1141
(3035350) Ketones [Presence] in Urine by Test strip
1047
9279
1.23
5.74
3.9
3.4
estimate
0.0
0.0
0.50
162
1641
(40768795) Lymph node Pathology biopsy report
16
41
3.92
5.71
1.4
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
238
1733
1.42
5.70
1.6
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1921
18224
1.31
5.63
3.9
3.7
mmol/l
1.3
1.3
0.47
1788
16891
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1002
8854
1.23
5.61
3.2
2.8
ug/l
101.2
93.8
0.29
949
8266
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
235
1720
1.41
5.47
1.6
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1400
12827
1.23
5.46
3.1
2.8
u/l
47.6
40.5
1.31
1320
12017
(3026782) Osmolality of Urine
398
3166
1.31
5.41
2.7
2.5
mosm/kgh2o
536.3
539.4
0.10
347
2660
(3027945) Reticulocytes/100 erythrocytes in Blood
223
1621
1.42
5.40
2.7
2.4
%
1.7
1.8
0.27
201
1430
(3021589) Normoblasts [#/volume] in Blood
917
8069
1.22
5.24
8.8
7.8
e9/l
0.0
0.0
0.35
728
6602
(3000492) Spirometry study
249
1857
1.38
5.20
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
565
1.67
5.15
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
321
2497
1.33
5.10
2.3
2.3
ug/g
82.8
111.4
2.38
249
1973
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
590
4974
1.25
4.99
1.7
1.6
mmol/l
1.4
1.4
0.09
533
4237
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
152
1044
1.49
4.98
1.6
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
92
563
1.66
4.97
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
237
1768
1.38
4.94
6.3
5.9
mmol/l
104.7
104.3
0.77
232
1723
(42529406) Shigella sp [Presence] in Stool by Culture
93
573
1.65
4.89
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
638
5438
1.24
4.87
2.5
2.3
u/l
54.3
57.5
1.81
587
5017
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
496
4110
1.26
4.86
2.0
1.8
mg/l
1.1
1.0
0.45
377
3074
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
89
2.71
4.84
1.3
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
111
720
1.57
4.74
6.9
8.5
mmol/l
24.0
24.4
0.72
102
664
(3009214) Lutropin [Units/volume] in Serum or Plasma
87
538
1.64
4.54
1.5
1.3
u/l
8.5
10.6
1.10
71
440
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
623
5332
1.23
4.52
2.0
2.1
u/l
139.8
227.2
2.89
590
4999
(3042936) Bacteria identified in Isolate by Culture
284
2215
1.32
4.43
2.0
2.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
12
7.52
4.35
1.1
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
292
2293
1.31
4.34
2.8
2.4
g/l
2.4
2.4
0.17
276
2125
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
76
461
1.67
4.29
3.9
2.6
g/l
3.7
3.6
0.44
70
430
(3047181) Lactate [Moles/volume] in Blood
78
479
1.65
4.20
4.5
7.1
mmol/l
1.1
1.2
0.34
68
421
(3035637) Corticotropin [Mass/volume] in Plasma
36
173
2.10
4.17
1.3
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
56
316
1.79
4.09
5.0
8.9
mmol/l
10.6
11.1
0.53
49
284
(3011412) CD3 cells [#/volume] in Blood
25
104
2.42
4.06
2.6
2.1
e9/l
1.2
1.2
—
10
57
(3018572) Chloride [Moles/volume] in Blood
56
317
1.79
4.05
5.0
8.9
mmol/l
105.0
105.0
0.02
49
285
(3023520) Reticulocytes [#/volume] in Blood
160
1157
1.41
4.04
2.7
2.4
e9/l
68.4
70.3
0.27
119
881
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
54
304
1.79
3.98
1.3
1.2
ug/l
3.0
3.3
0.23
45
284
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
81
2.61
3.97
1.5
2.0
%
10.1
13.1
0.92
12
47
(3052851) Hemolysis interference index of Serum or Plasma
76
474
1.62
3.88
2.5
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
150
1083
1.41
3.84
1.3
1.3
iu/l
24.8
27.2
0.39
135
936
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
123
856
1.46
3.84
6.9
8.5
%
0.7
0.7
0.36
123
850
(4281824)
25
107
2.35
3.83
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
483
4096
1.23
3.76
2.0
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
263
2079
1.30
3.73
3.0
2.5
%
22.5
23.8
0.84
222
1776
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
85
2.48
3.63
2.7
2.0
e9/l
0.2
0.2
0.77
16
73
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
202
1548
1.33
3.59
1.3
1.2
iu/ml
123.3
149.9
0.51
80
620
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
47
264
1.80
3.53
1.3
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
21
87
2.43
3.47
2.7
2.0
e6/l
480.3
513.5
0.12
16
73
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
87
577
1.53
3.46
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
457
3887
1.22
3.44
1.5
1.3
g/l
2.1
2.3
2.47
268
2381
(3022948) Iron [Moles/volume] in Serum or Plasma
312
2552
1.26
3.38
2.8
2.4
umol/l
76.8
14.0
0.49
299
2357
(40768441) Liver Pathology biopsy report
23
101
2.29
3.36
1.2
1.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
120
862
1.41
3.21
7.1
8.4
%
1.3
1.4
0.51
120
856
(3037756) Immunofixation for Serum or Plasma
43
243
1.78
3.19
1.5
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
89
605
1.49
3.17
2.4
1.8
g/l
1.2
1.5
2.09
75
523
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
207
1.85
3.17
1.2
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
128
932
1.40
3.17
3.8
5.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
106
748
1.44
3.13
1.4
1.3
miu/ml
240.1
227.3
0.12
49
363
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
166
1.94
3.09
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
223
1771
1.29
3.08
1.9
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
275
2241
1.26
3.08
1.8
1.6
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
8
7.52
3.05
1.2
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
629
5570
1.18
3.01
3.2
3.1
mmol/l
7.7
7.5
0.49
550
4744
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
181
1408
1.31
2.93
1.8
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
79
534
1.50
2.92
2.0
2.0
iu/l
2.8
4.6
1.99
22
202
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
453
3909
1.20
2.92
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
382
1.59
2.90
2.7
4.0
u/ml
0.4
0.4
0.07
35
228
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
122
899
1.38
2.84
2.5
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
529
4638
1.18
2.84
1.3
1.3
u/ml
0.7
1.8
5.68
122
1274
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
92
646
1.44
2.82
1.9
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
47
2.78
2.81
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
117
861
1.38
2.76
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
480
4184
1.19
2.75
4.5
3.7
kg/l
1.0
1.0
0.23
62
606
(3028026) IgM [Mass/volume] in Serum or Plasma
130
974
1.35
2.74
2.0
1.5
g/l
1.9
1.2
0.74
118
891
(3037522) Nuclear Ab [Titer] in Serum
330
2780
1.22
2.73
1.4
1.3
titre
734.2
556.3
0.50
73
578
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
924
1.36
2.71
5.3
7.3
mmol/l
24.7
24.6
0.13
114
853
(3000060) B lymphocytes [#/volume] in Blood
11
37
2.98
2.69
1.5
2.2
e6/l
146.0
156.4
—
5
22
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
70
471
1.50
2.67
6.8
2.5
%
182.3
174.5
0.31
64
448
(3004716) Salmonella sp identified in Stool by Organism specific culture
147
1128
1.32
2.65
1.4
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
51
322
1.60
2.58
1.5
1.4
nmol/l
0.3
0.4
0.37
43
272
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
38
2.90
2.58
1.2
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
593
5285
1.16
2.58
3.8
3.9
mg/mmol
12.9
8.4
0.71
368
3278
(40760892) CBC W Ordered Manual Differential panel - Blood
485
4258
1.18
2.54
3.8
4.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
44
2.74
2.54
1.1
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
44
2.74
2.54
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
44
2.74
2.54
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
40
239
1.69
2.51
1.6
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
301
1.61
2.51
1.2
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
75
2.28
2.51
1.6
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
23
115
2.01
2.51
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
303
1.60
2.45
1.6
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
243
2008
1.23
2.44
22.6
23.7
inr
1.2
1.3
0.53
38
310
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
280
1.62
2.43
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
132
1013
1.32
2.40
2.1
2.1
u/l
4327.9
5416.3
0.17
53
424
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
258
1.64
2.39
6.0
5.1
iu/ml
188.1
475.2
—
7
33
(3012516) Albumin [Mass/volume] in Urine
563
5026
1.16
2.38
3.3
3.2
mg/l
198.2
259.9
0.18
366
3102
(3008536) Aspergillus sp Ab [Presence] in Serum
7
17
4.13
2.36
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
48
307
1.58
2.33
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
307
1.58
2.33
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
458
4032
1.17
2.32
1.6
1.5
nmol/l
20.9
20.9
0.03
405
3467
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
133
1.89
2.31
1.3
1.5
—
—
—
0
0
(4010399)
162
1287
1.28
2.29
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
115
875
1.33
2.24
2.2
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
9
5.56
2.21
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
45
288
1.57
2.20
1.7
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
207
1705
1.23
2.16
2.3
1.8
nmol/l
378.1
370.3
0.24
191
1548
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
115
881
1.32
2.15
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
82
597
1.39
2.13
1.8
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
163
1312
1.26
2.09
2.7
3.0
ng/l
103.2
181.1
5.85
147
1189
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
397
3488
1.17
2.06
1.3
1.3
u/ml
5.1
10.0
1.67
143
1411
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
89
2.03
2.05
2.4
2.2
ug/l
18.9
108.6
0.51
18
80
(4211845)
19
96
1.99
2.05
3.3
3.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
334
1.51
2.04
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
125
1.85
2.02
1.0
1.1
iu/ml
2.0
14.9
—
8
30
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
147
1.78
2.02
3.3
3.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
39
247
1.59
2.01
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
77
561
1.39
2.01
1.1
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
90
2.01
2.00
3.3
2.2
e6/l
663.2
905.7
—
9
36
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
107
822
1.32
1.98
1.3
1.3
u/ml
1.3
0.8
0.14
12
67
(3025941) Bacteria identified in Stool by Culture
138
1101
1.27
1.93
1.4
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
33
2.73
1.93
1.3
1.4
ng/l
127.2
84.9
—
9
33
(3022689) Creatine [Moles/volume] in Urine
13
58
2.25
1.90
1.2
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
153
1238
1.25
1.90
2.7
2.3
g/l
10.0
10.7
1.07
141
1128
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
502
4514
1.14
1.90
2.4
2.2
mg/l
2.8
2.8
0.14
443
3850
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
395
0.58
1.89
3.9
3.6
mg/l
43.5
24.7
0.68
16
258
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
100
767
1.32
1.89
1.8
2.0
u/l
38.6
39.3
0.19
90
692
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
59
415
1.43
1.89
2.3
2.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
61
433
1.42
1.86
1.1
1.4
—
19.2
—
0
9
(40768806) Pleura Pathology biopsy report
15
72
2.09
1.86
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
309
1.50
1.86
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
182
1.66
1.85
1.5
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
285
1.52
1.85
1.9
1.7
g/l
0.9
0.8
0.11
37
214
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
285
1.52
1.85
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
86
648
1.34
1.84
3.5
2.0
s
21.4
20.8
0.47
69
551
(3007930) Methemoglobin/Hemoglobin.total in Blood
80
597
1.35
1.82
4.2
5.8
%
0.9
0.9
0.05
73
561
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
27
160
1.70
1.82
2.5
2.9
mg/l
17.8
19.8
0.06
21
114
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
145
1.73
1.81
1.2
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
35
2.58
1.80
1.2
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
78
582
1.35
1.79
2.0
1.7
g/l
0.2
0.2
0.37
73
552
(3002032) Base excess in Venous blood by calculation
167
1376
1.23
1.78
4.8
3.3
mmol/l
1.5
2.0
1.08
133
1110
(3009466) Valproate [Moles/volume] in Serum or Plasma
15
285
0.52
1.76
6.8
5.4
umol/l
412.3
372.9
0.59
15
242
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
80
601
1.34
1.76
4.1
5.7
%
1.7
1.7
0.14
73
563
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
52
365
1.43
1.71
1.5
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
48
332
1.46
1.70
5.6
2.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
48
2.30
1.70
2.4
4.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
39
259
1.51
1.68
1.3
1.2
nmol/l
—
0.4
—
0
15
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
376
3344
1.15
1.67
1.8
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
55
2.19
1.67
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
187
2212
0.83
1.65
4.2
4.3
%
33.5
32.6
0.57
128
1536
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
16
83
1.93
1.64
14.9
1.9
%
115.2
122.7
0.18
16
78
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
45
310
1.46
1.64
1.5
1.4
u/l
19.1
25.2
0.78
38
244
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
48
335
1.44
1.64
1.5
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
893
1.27
1.62
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
174
1.62
1.61
1.3
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
77
1.95
1.59
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
121
1.74
1.58
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
64
474
1.36
1.57
1.9
1.8
ug/l
1.0
1.7
0.74
54
408
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
404
3631
1.14
1.54
1.3
1.3
iu/ml
33.3
32.3
0.03
109
1126
(3025130) Human papilloma virus identified in Specimen
47
331
1.43
1.54
1.7
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
33
2.43
1.53
1.8
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
169
1420
1.21
1.52
1.6
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
163
1367
1.21
1.50
2.4
2.4
au/ml
40.1
23.3
—
9
89
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
131
1.69
1.49
1.7
1.6
—
—
—
0
0
(4268621)
32
210
1.53
1.48
2.4
2.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
65
2.01
1.48
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
569
5234
1.12
1.48
1.5
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
91
717
1.28
1.47
6.3
3.7
mmol/l
24.1
24.2
0.21
83
636
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
35
235
1.50
1.47
1.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
38
2.37
1.45
4.4
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
52
2.12
1.44
1.5
2.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
16
3.13
1.44
1.4
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
81
632
1.29
1.42
1.6
1.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
34
229
1.49
1.41
1.7
1.5
mu/l
21.8
49.8
2.17
29
208
(3006462) Nitrate [Presence] in Urine
16
88
1.82
1.41
3.7
3.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
29
2.42
1.39
1.9
1.2
nmol/l
5.3
5.8
—
7
29
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
142
1.63
1.38
1.1
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
20
119
1.69
1.37
1.5
1.3
umol/l
5.5
5.1
0.19
20
113
(3021447) Carbon dioxide [Partial pressure] in Venous blood
164
1390
1.19
1.37
4.9
3.2
kpa
5.8
5.9
0.10
156
1342
(3015235) Bicarbonate [Moles/volume] in Capillary blood
49
358
1.38
1.34
2.0
3.2
mmol/l
24.4
24.9
0.49
42
316
(3005322) IgE [Units/volume] in Serum or Plasma
160
1357
1.19
1.33
1.3
1.3
u/ml
166.3
207.4
0.57
155
1246
(3010726) Horse dander IgE Ab [Units/volume] in Serum
51
376
1.36
1.32
1.1
1.1
u/ml
2.8
2.9
0.00
17
98
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
61
1.97
1.32
1.1
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
61
1.97
1.32
1.1
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
61
1.97
1.32
1.1
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
61
1.97
1.32
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
113
1.69
1.31
1.4
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
44
317
1.40
1.31
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
148
1249
1.20
1.30
3.0
2.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
21
129
1.63
1.30
2.4
2.1
%
12.3
10.9
0.89
21
129
(4062490)
28
185
1.52
1.29
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
34
2.36
1.29
1.4
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
138
1160
1.20
1.27
2.8
1.5
g/l
67.4
67.4
0.02
129
1046
(3004588) Protein electrophoresis panel - Serum or Plasma
118
979
1.22
1.25
2.7
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
25
2.40
1.24
4.0
5.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
220
1.46
1.23
1.4
1.4
pmol/l
311.4
316.1
0.04
25
164
(3035320) C reactive protein [Mass/volume] in Body fluid
21
131
1.61
1.23
1.9
2.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
60
460
1.31
1.23
1.2
1.1
u/ml
0.7
1.5
0.83
30
183
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
482
4439
1.11
1.22
2.8
2.9
ng/l
1117.3
1232.5
0.26
388
3714
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
19
2.63
1.21
1.4
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
293
2625
1.13
1.20
2.0
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
52
392
1.33
1.20
1.2
1.1
u/ml
0.9
1.2
0.14
29
169
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
315
1.37
1.18
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
326
2944
1.12
1.18
2.0
2.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
26
173
1.51
1.18
3.7
3.0
%
1.8
1.2
0.34
18
125
(3028626) Oxygen [Partial pressure] in Capillary blood
42
307
1.37
1.17
1.9
2.8
kpa
8.5
8.2
0.50
37
283
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
33
231
1.43
1.17
1.3
1.2
nmol/l
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
57
1.93
1.17
1.2
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
34
0.00
1.16
0.0
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
308
1.37
1.16
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
104
860
1.22
1.15
1.9
1.6
mu/l
317.2
300.4
0.23
96
770
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
20
2.50
1.15
1.6
1.4
%
30.2
33.4
—
5
14
(3004775) Volume in Urine collected for unspecified duration
20
126
1.59
1.14
2.5
2.3
ml
693.9
610.2
0.54
15
91
(3013139) Helicobacter pylori Ag [Presence] in Stool
151
1295
1.18
1.14
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
191
1669
1.16
1.14
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
65
1.85
1.13
3.1
2.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
58
1.90
1.12
1.4
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
40
2.00
1.12
1.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
40
2.00
1.12
1.1
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
164
1419
1.17
1.11
2.0
2.3
ug/l
5.0
7.0
1.22
136
1240
(3003888) Timothy IgE Ab [Units/volume] in Serum
53
406
1.31
1.11
1.2
1.1
u/ml
7.0
5.1
0.36
36
219
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.6
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
39
286
1.37
1.09
2.6
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
41
1.95
1.08
1.6
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
128
1.57
1.08
2.5
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
244
1.40
1.07
1.7
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
89
1.69
1.07
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
131
1117
1.18
1.07
1.1
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
401
1.30
1.05
1.9
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
9
46
1.96
1.03
1.1
1.1
u/ml
63.2
42.5
—
9
46
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
22
2.28
1.03
1.6
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
315
1.34
1.03
1.4
1.4
u/ml
102.3
104.4
—
7
55
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
21
138
1.53
1.03
1.3
1.1
titre
70.0
166.0
—
6
30
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
298
1.35
1.02
1.2
1.3
u/ml
4.7
4.8
0.03
19
130
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
122
1.56
1.02
6.8
3.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
122
1.56
1.02
3.6
3.0
%
59.8
54.6
—
8
79
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
395
1.30
1.01
3.0
1.5
mg/l
153.0
39.3
0.62
37
329
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
395
1.30
1.01
3.0
1.5
mg/l
28.1
44.5
0.56
37
329
(3012441) Differential panel - Pleural fluid
15
91
1.65
1.00
1.5
1.5
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
12
68
1.77
1.00
1.3
1.5
pmol/l
12.5
13.9
0.59
12
58
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
396
1.29
0.99
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
115
1.57
0.99
1.4
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
539
1.25
0.99
2.8
1.4
g/l
3.1
3.0
0.06
56
422
(4034850)
50
638
0.78
0.98
15.6
8.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
275
1.35
0.97
1.7
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
93
777
1.21
0.97
1.8
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
12
69
1.74
0.96
2.7
1.8
ug/l
1.4
1.1
0.35
12
61
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
579
0.77
0.95
1.4
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
242
1.37
0.94
1.9
2.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
37
1.89
0.94
1.1
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
37
1.89
0.94
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
40
303
1.33
0.94
2.1
2.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
183
1.43
0.93
1.3
1.5
g/l
3.1
2.9
0.23
21
125
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
312
1.32
0.93
1.2
1.3
u/ml
4.5
4.5
0.00
15
102
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
150
1.47
0.93
1.5
1.2
u/l
43.3
56.3
0.88
12
104
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
28
2.15
0.91
1.3
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
23
159
1.45
0.91
1.7
1.5
g/l
0.8
1.0
2.16
23
159
(3013512) EKG study
516
4839
1.09
0.90
3.5
3.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
352
3811
0.91
0.90
1.6
1.6
pmol/l
431.5
40947766.2
4.16
302
3209
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
53
421
1.26
0.89
1.6
1.4
e6/l
143.7
1660.9
1.53
42
350
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
53
421
1.26
0.89
1.5
1.3
e6/l
24.4
31.4
0.15
41
334
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
135
1.49
0.89
1.1
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
71
1.69
0.88
1.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
71
1.69
0.88
1.6
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
37
280
1.33
0.88
1.1
1.1
u/ml
0.8
0.4
0.30
12
68
(3019977) pH of Arterial blood
13
79
1.65
0.88
1.7
2.6
ph
7.4
7.4
—
6
23
(3051651) Icteric interference index of Serum or Plasma
13
79
1.65
0.88
2.1
3.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
10
56
1.79
0.87
1.6
1.2
u/l
14.6
9.5
—
10
49
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
30
2.00
0.87
1.7
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
30
2.00
0.87
1.8
1.4
—
—
—
0
0
(4094501)
60
486
1.24
0.86
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
64
778
0.82
0.85
1.4
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
31
1.94
0.84
1.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
132
1154
1.15
0.83
3.7
2.7
kpa
4.7
4.6
0.18
125
1112
(3023430) Cat dander IgE Ab [Units/volume] in Serum
39
301
1.30
0.83
1.1
1.1
u/ml
5.3
5.6
0.03
20
127
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
571
1.21
0.82
2.8
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
571
1.21
0.82
2.8
1.4
g/l
3.5
3.8
1.19
56
411
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
571
1.21
0.82
2.8
1.4
g/l
7.4
7.4
0.01
58
432
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
756
7218
1.07
0.82
4.0
3.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
113
1.51
0.82
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
46
575
0.80
0.80
1.4
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
242
1.33
0.79
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
151
1340
1.14
0.78
3.5
4.0
%
0.7
0.6
0.28
37
271
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
42
331
1.27
0.77
3.2
3.5
%
56.3
57.0
0.17
42
331
(40762814) Titanium [Mass/volume] in Blood
0
27
0.00
0.77
0.0
2.3
—
3.4
—
0
13
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
157
1.41
0.76
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
157
1.41
0.76
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
157
1.41
0.76
1.1
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
19
132
1.44
0.76
1.1
1.3
nmol/l
43.5
30.9
0.87
14
116
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
592
0.81
0.75
1.4
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
333
3094
1.09
0.74
1.6
1.7
nmol/l
1115.4
1169.2
0.53
244
2352
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
141
1.42
0.74
1.1
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
92
792
1.17
0.73
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
254
1.30
0.73
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
237
2170
1.10
0.73
8.0
5.9
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
308
1.27
0.72
1.1
1.0
u/ml
2.0
3.0
0.51
22
156
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
335
1.26
0.72
2.1
2.2
g/l
127.9
132.9
0.73
32
250
(3007566) Smooth muscle Ab [Titer] in Serum
59
489
1.21
0.72
1.3
1.2
titre
77.0
93.3
—
10
42
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
46
371
1.24
0.72
1.8
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
707
0.83
0.71
1.3
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
57
1.58
0.71
3.2
3.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
160
1.38
0.70
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
160
1.38
0.70
1.1
1.1
—
—
—
0
0
(44790047)
22
160
1.38
0.70
1.3
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
160
1.38
0.70
1.1
1.1
—
—
—
0
0
(44790049)
22
160
1.38
0.70
1.3
1.4
—
—
—
0
0
(44806118)
22
160
1.38
0.70
1.3
1.4
—
—
—
0
0
(44790048)
22
160
1.38
0.70
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
126
1.43
0.70
1.1
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
58
1.55
0.69
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
85
1.53
0.69
1.5
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
27
1.85
0.68
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
27
1.85
0.68
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
27
1.85
0.68
1.4
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
80
686
1.17
0.68
1.7
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
110
1.46
0.68
1.9
1.4
umol/l
18.0
23.1
0.33
16
103
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
259
2391
1.09
0.68
1.7
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
102
1.47
0.67
1.7
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
153
1.38
0.67
1.9
3.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
149
1340
1.12
0.65
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60
711
0.84
0.65
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
710
0.84
0.64
1.3
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
166
0.66
0.64
1.1
1.2
u/ml
0.0
1.3
—
6
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
672
6442
1.06
0.64
3.3
3.4
ng/l
23.5
64.1
2.05
389
3933
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
441
1.21
0.64
1.4
1.4
ug/g
315.5
322.4
0.08
29
236
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.4
nmol/l
7.1
1156526.2
—
5
23
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
113
1.42
0.61
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
139
0.65
0.60
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.1
—
1.8
—
0
13
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
10.3
—
0
5
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
163
0.67
0.60
1.2
1.2
—
63.3
—
0
19
(3022313) Gas panel - Capillary blood
59
693
0.85
0.60
3.9
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
326
1.23
0.59
3.3
3.4
e9/l
4.1
4.0
0.08
40
326
(40761535) Cells panel - Urine sediment
160
1455
1.11
0.59
3.9
3.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
11
162
0.68
0.58
1.2
1.1
—
56.4
—
0
10
(3010421) pH of Blood
31
387
0.80
0.58
3.5
3.4
ph
7.4
7.4
0.49
31
314
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
81
1.48
0.57
1.3
1.1
iu/ml
155.7
222.0
0.65
12
81
(3014133) Dog dander IgE Ab [Units/volume] in Serum
40
329
1.22
0.56
1.1
1.1
u/ml
0.7
4.8
3.60
19
128
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
61
708
0.86
0.55
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
518
4953
1.06
0.54
4.6
3.7
estimate
0.0
0.0
1.08
165
1657
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
195
1.29
0.54
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
231
1.26
0.54
1.1
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
62
1.45
0.53
1.0
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
9
62
1.45
0.53
4.0
9.8
mg/l
88.2
63.7
—
9
43
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
196
1.28
0.52
1.2
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
63
1.43
0.52
1.8
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
142
1295
1.10
0.52
3.7
4.1
%
0.0
0.1
3.57
33
250
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
100
1.40
0.51
2.3
2.0
—
—
—
0
0
(3020891) Body temperature
69
602
1.15
0.51
3.6
4.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
144
1.32
0.50
1.4
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
92
1.42
0.50
1.5
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
529
1.16
0.49
2.9
1.4
g/l
10.9
10.5
0.24
56
449
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
67
1.49
0.49
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
189
1.27
0.49
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
198
1.27
0.49
1.2
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
62
539
1.15
0.49
3.1
2.6
g/l
0.2
0.3
0.61
31
172
(3042733) HLA Ab [Presence] in Serum
7
45
1.56
0.49
4.6
4.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
46
1.52
0.48
1.3
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
77
868
0.88
0.48
2.2
1.7
mg/l
2.7
3.9
0.80
52
605
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
93
1.40
0.48
9.7
6.2
u/ml
56.6
63.6
—
5
22
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
71
625
1.14
0.48
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
190
1.27
0.48
1.2
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
47
1.49
0.47
1.6
3.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
47
1.49
0.47
1.7
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
47
1.49
0.47
1.6
3.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
80
711
1.13
0.47
4.1
2.5
%
1.4
1.2
0.40
80
704
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
419
0.83
0.47
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
68
1.47
0.47
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
32
386
0.83
0.46
4.0
4.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
69
608
1.14
0.46
1.1
1.1
u/ml
3.3
5.9
0.42
14
80
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
191
1.26
0.46
1.2
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
24
191
1.26
0.46
1.2
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
81
0.62
0.45
2.2
2.3
nmol/l
126.0
153.8
—
5
70
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
119
0.67
0.45
1.3
1.2
—
11.5
—
0
13
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
11
153
0.72
0.45
1.2
1.2
—
3.8
—
0
10
(3044927) Protein electrophoresis panel - Urine
12
164
0.73
0.45
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
34
283
1.20
0.45
2.5
3.1
umol/l
30.2
36.8
0.85
26
247
(3019832) Treponema pallidum Ab [Presence] in Serum
262
2471
1.07
0.45
1.6
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
481
0.85
0.44
1.2
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
33
275
1.20
0.43
1.6
1.4
mmol/l
62.1
66.7
0.27
26
224
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
128
0.70
0.43
20.3
13.0
nmol/l
975.4
853.0
—
9
123
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
175
1.26
0.43
1.1
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
33
276
1.20
0.42
2.3
1.9
—
4.6
—
0
5
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
530
5111
1.05
0.42
3.1
3.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
173
0.75
0.42
2.8
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
697
7177
0.96
0.41
2.5
2.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
2420.1
—
0
9
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
126
1367
0.92
0.41
1.4
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
306
1.18
0.39
1.2
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
35
1.43
0.39
4.4
2.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
6.6
2.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.3
—
5.5
—
0
9
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
36
1.39
0.38
2.0
2.3
mmol/l
1.2
1.2
—
5
36
(3002179) Metamyelocytes/100 leukocytes in Blood
134
1242
1.08
0.38
3.4
3.8
%
0.5
0.5
0.02
25
206
(4146454)
14
181
0.77
0.38
3.0
2.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
112
0.71
0.37
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
33
281
1.18
0.36
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
85
775
1.10
0.35
2.5
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
34
395
0.86
0.35
3.1
2.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
80
0.62
0.35
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
108
1.30
0.35
1.5
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(4133840)
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
319
0.84
0.34
1.6
2.1
umol/l
4.4
4.3
0.01
22
229
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
127
1.26
0.33
1.2
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
109
1.29
0.33
1.5
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
164
1.22
0.32
1.4
1.4
%
36.3
32.5
0.15
12
99
(4024509)
13
165
0.79
0.32
1.3
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
128
1.25
0.32
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
197
0.81
0.31
1.1
1.1
—
—
—
0
0
(4306422)
35
305
1.15
0.31
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
447
1.12
0.30
3.0
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
10
75
1.33
0.30
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
84
1.31
0.30
1.1
1.1
miu/ml
1443.3
1603.4
0.18
11
84
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
102
1.28
0.30
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
24
204
1.18
0.28
1.6
1.6
mmol/l
7.7
7.7
0.02
16
123
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
94
1.28
0.28
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
94
1.28
0.28
1.1
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
85
1.30
0.28
1.5
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.0
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
117
1246
0.94
0.27
2.9
2.7
mmol/l
1.2
1.2
0.40
101
1035
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
140
1.22
0.27
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
205
1.17
0.27
2.9
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
55
499
1.10
0.27
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
132
1244
1.06
0.27
3.8
4.1
%
0.0
0.4
0.53
29
225
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
394
1.12
0.27
2.8
2.4
ug/min
49.2
99.1
1.09
30
251
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
187
1.18
0.26
1.5
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
207
2164
0.95
0.26
1.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
67
1.19
0.26
1.1
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
149
0.80
0.25
1.2
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
9
73
1.23
0.25
1.1
1.2
—
0.1
—
0
6
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
1.1
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
95
890
1.07
0.24
1.7
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
50
548
0.91
0.24
1.5
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
84
0.71
0.24
1.5
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
21
180
1.17
0.23
1.2
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
77
826
0.93
0.23
1.4
1.5
—
—
—
0
0
(44813793)
17
143
1.19
0.23
1.1
1.1
—
—
—
0
0
(4015189)
5
38
1.32
0.23
1.2
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
304
1.12
0.22
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
253
0.87
0.22
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
95
0.74
0.22
1.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
607
0.92
0.22
1.5
1.6
iu/ml
0.0
0.2
—
10
119
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
41
1.22
0.22
2.0
1.1
pmol/l
338.2
261.4
—
5
28
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
163
1.17
0.21
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
8.6
—
0
11
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
206.4
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4038314)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
13
156
0.83
0.21
1.2
1.2
mg/l
39.6
39.9
0.01
13
128
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
363
1.10
0.21
1.1
1.2
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
12.6
—
0
12
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.0
—
4.7
—
0
6
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
43
393
1.10
0.20
1.3
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
39
428
0.91
0.20
1.2
1.2
—
10.9
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
278
1.12
0.20
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
68
635
1.07
0.20
1.4
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
344
0.90
0.19
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
99
1.21
0.19
1.7
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
120
1258
0.95
0.19
1.8
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
31
343
0.90
0.19
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
49
453
1.08
0.18
1.3
1.2
u/ml
27.0
46.3
—
6
44
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
10
81
1.24
0.18
1.3
1.1
u/l
99.3
76.0
—
10
61
(40767503) Oxygen content in Capillary blood by calculation
26
290
0.90
0.18
2.6
2.4
%
16.3
16.7
0.28
18
136
(3000475) Leukocytes [#/volume] in Synovial fluid
46
425
1.08
0.18
1.3
1.6
e6/l
22661.3
10656.5
0.35
31
315
(3050129) First trimester maternal screen panel - Serum or Plasma
94
893
1.05
0.17
1.4
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
10
82
1.22
0.17
1.3
1.1
u/l
39.5
16.8
—
10
57
(3000012) Reticulocyte production index
5
67
0.75
0.17
1.4
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
13
152
0.85
0.17
1.2
1.5
umol/l
9.8
11.6
0.53
13
141
(3012565) Volume of 24 hour Urine
5
70
0.71
0.16
1.6
2.1
ml
2082.8
2019.8
—
5
60
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
136
1309
1.04
0.16
3.0
2.6
e9/l
4.0
4.1
0.31
110
1033
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
233
2269
1.03
0.15
1.4
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
16
140
1.14
0.15
1.5
1.3
—
1.6
—
0
12
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
29
317
0.91
0.15
1.0
1.1
iu/ml
82.8
1846.7
—
5
72
(4198724)
7
90
0.78
0.14
3.0
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
131
1.15
0.14
4.0
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
202
0.89
0.14
1.1
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
28
256
1.09
0.14
1.2
1.3
—
50.3
—
0
16
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
353
1.08
0.14
1.4
1.2
u/ml
201.0
239.2
0.55
22
229
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
222
0.90
0.13
1.0
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
149
0.87
0.13
1.2
1.1
mg/l
271.6
252.0
0.12
13
130
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
132
1.14
0.13
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
180
1.11
0.13
1.2
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
14
123
1.14
0.12
1.0
1.0
u/ml
0.1
4.6
—
5
18
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
152
1.12
0.12
1.7
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
168
0.89
0.11
1.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
53
558
0.95
0.11
1.2
1.3
u/ml
2.6
6.0
—
6
103
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
134
1.12
0.11
1.5
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
309
1.07
0.10
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
86
891
0.96
0.10
2.0
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
203
1.08
0.09
2.1
2.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
87
1.15
0.09
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
124
0.89
0.09
2.3
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
97
1.13
0.09
1.2
1.5
nmol/l
149.9
140.1
0.42
11
97
(3011288) Drugs identified in Urine by Screen method
65
626
1.04
0.09
2.7
2.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
15
165
0.91
0.09
1.0
1.2
nmol/l
422.1
402.1
0.16
15
150
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
53
552
0.96
0.08
1.3
1.2
u/ml
2.2
7.6
—
5
58
(3015183) Erythrocyte sedimentation rate
11
123
0.89
0.08
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
67
1.04
0.08
1.4
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
67
1.04
0.08
1.1
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
7
68
1.03
0.07
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
237
2406
0.98
0.07
1.6
1.7
%
1.4
1.4
0.50
205
2135
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
70
0.86
0.07
1.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
74
0.81
0.07
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
78
1.03
0.07
1.0
1.6
u/l
198.6
188.0
—
8
78
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
81
0.86
0.07
1.6
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
87
1.03
0.07
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
177
1.07
0.06
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
234
0.94
0.06
1.3
1.5
%
58.6
59.6
0.03
11
151
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
28
295
0.95
0.06
1.5
1.4
mmol/l
7.1
7.4
0.25
21
211
(3041806) Other cells [#/volume] in Blood by Manual count
9
100
0.90
0.06
2.2
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
187
1.07
0.06
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
305
1.05
0.06
3.4
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
374
1.04
0.06
1.4
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
86
881
0.98
0.06
2.0
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
109
1.10
0.06
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
158
1.08
0.06
2.9
2.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
55
533
1.03
0.06
3.3
3.7
mmol/l
1.2
1.4
0.96
55
522
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
192
1946
0.99
0.05
1.8
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
708
0.97
0.05
2.1
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
85
831
1.02
0.05
1.9
2.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
110
1.09
0.05
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
367
1.04
0.04
1.5
2.2
nmol/l
0.7
0.8
0.47
32
300
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
129
0.93
0.03
1.5
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
34
329
1.03
0.03
1.2
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
118
0.93
0.02
1.0
1.0
ng/l
51.2
50.6
—
5
74
(3000330) Specific gravity of Urine by Test strip
87
882
0.99
0.02
3.4
3.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
132
1.06
0.02
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
89
899
0.99
0.01
1.9
1.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
277
0.97
0.01
3.4
3.2
nmol/l
0.8
0.8
0.13
19
216
(3009343) pH of Capillary blood
92
928
0.99
0.01
3.4
3.2
ph
7.4
7.4
0.70
13
101
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
162
1612
1.01
0.01
3.0
2.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
136
0.96
0.00
1.2
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
316
0.98
0.00
3.4
3.6
mmol/l
2.8
2.6
0.17
19
202
(3021788) Differential panel - Synovial fluid
33
324
1.02
0.00
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
67
664
1.01
0.00
1.7
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
115
0.96
0.00
1.0
1.0
ng/l
343.0
345.2
—
5
76
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
115
0.96
0.00
1.0
1.0
ng/l
678.4
688.7
—
5
74
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
165
0.97
0.00
1.1
1.3
e6/l
23578.0
121923.8
—
9
109
(4027681)
12
121
0.99
0.00
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
60
595
1.01
0.00
1.7
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
379
1.00
0.00
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
114
0.96
0.00
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
163
1629
1.00
0.00
4.6
3.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
118
1.02
0.00
1.3
1.1
u/l
0.9
1.1
—
7
57
(3027008) Opiates [Presence] in Urine
89
894
1.00
0.00
1.9
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
152
1524
1.00
0.00
3.6
3.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
94
942
1.00
0.00
3.4
3.3
kpa
5.1
5.2
1.00
85
876
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
52
517
1.01
0.00
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
64
637
1.00
0.00
1.8
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
897
1.00
0.00
3.4
3.2
mmol/l
1.5
1.7
0.28
58
647
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
7.6
—
0
9
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
68.6
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
0.5
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
68.8
—
0
5
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
896.6
—
0
9
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
72
0.97
0.00
2.0
2.4
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
124.4
—
0
6
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
71
0.99
0.00
1.1
1.5
—
1431193.8
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
53
0.94
0.00
1.2
1.2
%
47.3
53.6
—
5
46
(3017569) Oxygen content in Arterial blood
8
83
0.96
0.00
1.6
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
78
0.90
0.00
1.1
2.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
9
93
0.97
0.00
1.7
2.0
ug/l
1.2
2.4
—
9
82
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.7
—
250.2
—
0
6
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
3.1
—
0
8
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
0.0
—
0
7
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.1
—
348.1
—
0
7
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE_EXALLC – Melanocytic naevi of other and unspecified parts of face
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).